Current role
Biotechnology · Healthcare
Chairman
2024-01-04–present
Willian H. Lewis, J.D., M.B.A.
Chairman
NewAmsterdam Pharma Co N.V. (NAMS)Equibles does not estimate personal net worth.
Get an email with a short summary when NewAmsterdam Pharma Co N.V. publishes a filing, an earnings call transcript or a press release.
Get NAMS alertsAbout Willian H. Lewis, J.D., M.B.A.
Willian H. Lewis, J.D., M.B.A. is recorded as Chairman at NewAmsterdam Pharma Co N.V. (NAMS) since January 4, 2024. NewAmsterdam Pharma Co N.V. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NewAmsterdam Pharma Co N.V. includes Michael Davidson (CEO), Ian Somaiya (CFO), Robert W. Gunning (Chief Accounting Officer) and 3 others.
Affiliation history
-
Current
2024-01-04–present
Company network
Leadership on record at NewAmsterdam Pharma Co N.V.
- Michael Davidson CEO
- Ian Somaiya CFO
- Robert W. Gunning Chief Accounting Officer
- Adele Gulfo Board Member
- Mark C. McKenna Board Member
- Wouter Joustra Board Member
Recent activity
No call appearances or filed executive changes recorded yet.